$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Total Non-Current Assets
$643.00M
Quarterly · Period ending: · USD

RARE Total Non-Current Assets
Latest reported$581.00Mperiod ending
Latest reported$581.00Mperiod ending
RARE FY Non-Current Assets ($1.18M → $581.00M)
Annual total non-current assets
High-resolution chart · PNG
What is total non-current assets?
Long-term assets expected to provide value beyond one year.
RARE total non-current assets history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Assets (USD) |
|---|---|
| 581,000,000 | |
| 686,333,000 | |
| 758,829,000 | |
| 661,545,000 | |
| 665,793,000 | |
| 464,251,000 | |
| 284,479,000 | |
| 197,189,000 | |
| 246,285,000 | |
| 42,515,000 | |
| 109,362,000 | |
| 10,480,000 | |
| 4,424,000 | |
| 1,871,000 | |
| 1,176,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance